BOHEMIA, N.Y.--(BUSINESS WIRE)--Aug. 3, 2006--Advanced BioPhotonics Inc. (OTCBB: ABPH): -- Beth Israel Deaconess Medical Center To Serve As The Fourth Pilot Research Site To Investigate The Unique Use Of Company’s DIRI(R) Technology In Identifying Perforator Vessels In Plastic And Reconstructive Surgery Procedures. Advanced BioPhotonics Inc. (OTCBB: ABPH) a developer of next generation medical imaging applications using advanced infrared technology announced today that it has entered into an agreement with Beth Israel Deaconess Medical Center (BIDMC), a teaching hospital of Harvard Medical School. BIDMC will participate in the Company’s multi-center clinical trial investigating the use of Advanced BioPhotonics’ proprietary DIRI(R) method of dynamic infrared imaging in mapping vascular perforator blood vessels in Plastic and Reconstructive Surgery procedures.
